IL254053B - Nanoparticles of hollow silica with thermalized biologically active components, a process for their preparation and their applications - Google Patents

Nanoparticles of hollow silica with thermalized biologically active components, a process for their preparation and their applications

Info

Publication number
IL254053B
IL254053B IL254053A IL25405317A IL254053B IL 254053 B IL254053 B IL 254053B IL 254053 A IL254053 A IL 254053A IL 25405317 A IL25405317 A IL 25405317A IL 254053 B IL254053 B IL 254053B
Authority
IL
Israel
Prior art keywords
applications
preparation process
silica nanoparticles
hollow silica
bioactive ingredients
Prior art date
Application number
IL254053A
Other languages
English (en)
Hebrew (he)
Other versions
IL254053A0 (en
Original Assignee
Univ Nat Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Taiwan filed Critical Univ Nat Taiwan
Publication of IL254053A0 publication Critical patent/IL254053A0/en
Publication of IL254053B publication Critical patent/IL254053B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C01B33/146—After-treatment of sols
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/01—Particle morphology depicted by an image
    • C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Manufacturing & Machinery (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL254053A 2016-08-19 2017-08-17 Nanoparticles of hollow silica with thermalized biologically active components, a process for their preparation and their applications IL254053B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662376920P 2016-08-19 2016-08-19

Publications (2)

Publication Number Publication Date
IL254053A0 IL254053A0 (en) 2017-09-28
IL254053B true IL254053B (en) 2021-03-25

Family

ID=59655956

Family Applications (1)

Application Number Title Priority Date Filing Date
IL254053A IL254053B (en) 2016-08-19 2017-08-17 Nanoparticles of hollow silica with thermalized biologically active components, a process for their preparation and their applications

Country Status (10)

Country Link
US (1) US10729783B2 (fr)
EP (1) EP3284483B1 (fr)
JP (1) JP7075649B2 (fr)
CN (2) CN113499319B (fr)
AU (1) AU2017216585B2 (fr)
CA (1) CA2976857C (fr)
DK (1) DK3284483T3 (fr)
ES (1) ES2797779T3 (fr)
IL (1) IL254053B (fr)
TW (1) TWI705828B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018182518A1 (fr) * 2017-03-30 2018-10-04 Agency For Science, Technology And Research Procédé de préparation de nanocapsules de silice et nanocapsules de silice
CN111182891B (zh) 2017-05-19 2022-08-09 康奈尔大学 官能化纳米颗粒及其制备和使用方法
US20220081570A1 (en) * 2018-03-06 2022-03-17 Christopher Hendrickson Biodegradable hollow nanoparticles and methods and apparatus for manufacturing the same
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108751208B (zh) * 2018-06-05 2020-06-30 山东师范大学 一种无表面活性剂微乳液制备的单分散二氧化硅纳米球及其制备方法
WO2020234871A1 (fr) * 2019-05-20 2020-11-26 Technion Research & Development Foundation Limited Nanoparticules d'encapsulation de métabolite pour améliorer l'immunothérapie anticancéreuse cellulaire
CN110108656A (zh) * 2019-05-31 2019-08-09 吉林大学 一种介孔有机硅中空纳米球固定尿酸酶检测尿酸的方法
CN112239209B (zh) * 2019-07-18 2024-01-12 奈力生医股份有限公司 通过孔改性的介孔二氧化硅纳米颗粒进行的药物递送
JP2021042193A (ja) * 2019-07-18 2021-03-18 ナノ ターゲティング アンド セラピー バイオファーマ インコーポレイテッド 免疫療法用シリカナノスフェア
KR102349021B1 (ko) * 2020-01-08 2022-01-10 에이비씨나노텍 주식회사 기능성 체질안료를 함유하는 화장료 조성물의 제조방법 및 그에 따른 기능성 체질안료를 함유하는 화장료 조성물
WO2021226178A1 (fr) * 2020-05-08 2021-11-11 Nieder Matthew Herbert Composition d'uricase stable
CA3195153A1 (fr) * 2020-10-27 2022-05-05 Elucida Oncology, Inc. Conjugues de medicament a nanoparticules ciblees de recepteur de folate et leurs utilisations
CN112322035B (zh) * 2020-11-12 2021-06-08 华东理工大学 一种三层介孔空心二氧化硅-含氟聚苯并二噁唑复合薄膜及其制备方法和应用
CN114376983B (zh) * 2021-12-16 2023-08-29 中科清风康健医学研究(北京)有限公司 一种适用于高尿酸人群的天然提取物复合颗粒剂
CN114209851B (zh) * 2021-12-17 2023-08-29 同济大学 一种姜黄素-氧化硅纳米载药体系及其制备方法和应用
JP2023118050A (ja) * 2022-02-11 2023-08-24 ナノ ターゲティング アンド セラピー バイオファーマ インコーポレイテッド 脳癌又は脳転移の予防及び治療のための薬物負荷型メソ多孔質シリカナノ粒子
WO2024103168A1 (fr) * 2022-11-14 2024-05-23 Medisca Pharmaceutique Inc. Procédés et systèmes de fabrication de poudres chargées d'huile et leur utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
AU2004207813B8 (en) * 2003-01-24 2010-04-22 Health Research, Inc. Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles
EP1853318B1 (fr) * 2005-02-14 2016-05-18 Australian Nuclear Science And Technology Organisation Nanoparticules en couches
KR100950548B1 (ko) * 2008-01-10 2010-03-30 연세대학교 산학협력단 다공성 중공 실리카 나노입자, 그의 제조 방법, 상기를포함하는 약물 전달체 및 약제학적 조성물
WO2011008939A2 (fr) * 2009-07-16 2011-01-20 Medical College Of Georgia Research Institute, Inc. Microsphères de verre creuses à paroi poreuse en tant que supports pour biomolécules
US8974709B2 (en) * 2010-06-25 2015-03-10 Colabs Intl Corp Ceramic encapsulation with controlled layering by use of prehydrolyzed functionalized silanes
EP3283435B1 (fr) * 2015-04-17 2021-06-09 The University of Queensland Composition, matériaux sous forme de particules et procédés de fabrication de matériaux sous forme de particules

Also Published As

Publication number Publication date
ES2797779T3 (es) 2020-12-03
CN113499319B (zh) 2023-07-07
AU2017216585B2 (en) 2022-12-22
JP7075649B2 (ja) 2022-05-26
EP3284483B1 (fr) 2020-03-11
EP3284483A1 (fr) 2018-02-21
JP2018115145A (ja) 2018-07-26
AU2017216585A1 (en) 2018-03-08
US10729783B2 (en) 2020-08-04
CN113499319A (zh) 2021-10-15
TWI705828B (zh) 2020-10-01
DK3284483T3 (da) 2020-05-18
CN107753464B (zh) 2021-11-16
TW201811370A (zh) 2018-04-01
CA2976857A1 (fr) 2018-02-19
CN107753464A (zh) 2018-03-06
IL254053A0 (en) 2017-09-28
CA2976857C (fr) 2024-06-25
US20180050115A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
IL254053A0 (en) Nanoparticles of hollow silica with thermalized biologically active components, a process for their preparation and their applications
IL256673B (en) Devices for in vitro vascular perfusion, methods of making and their applications
PL3760176T3 (pl) Rdzeń chłonny, wyroby zawierające wspomniany rdzeń, i sposoby wytwarzania
PL3630917T4 (pl) Równomiernie zamknięte nanocząstki i ich zastosowania
GB2564343B (en) Composites, methods of manufacture thereof, and articles containing the composites
ZA201803244B (en) High-performance glass fibre composition, glass fibre and composite material therefrom
SG10202102922UA (en) Manufacturing line, process, and sintered article
EP3262122A4 (fr) Composition de polyamide comprenant des microsphères creuses de verre et objets et procédés associés
HK1245208A1 (zh) 內部中空體、模具及其製造方法
HUE050313T2 (hu) Kerámia phoswich egyesített optikai elemekkel, eljárás annak elõállítására és azt tartalmazó termékek
HK1254730A1 (zh) 可可提取物、可可產品及其製造方法
EP3360629A4 (fr) Procédé de préparation de nouveaux nanofils d'argent à rapport d'aspect et à nuds uniformes
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
ZA201708661B (en) High-performance glass fiber composition, and glass fiber and composite material thereof
HK1232171A1 (zh) 無賽璐珞的基本上球形中空體及其製作
ZA201903928B (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
EP3289015A4 (fr) Composition polymère, article moulé, et procédé de fabrication de l'article moulé
PL3506918T3 (pl) Kompozycja zawierająca ekstrakty z pyłków i/lub słupków, sposób wytwarzania i powiązane zastosowanie
EP3392016A4 (fr) Procédé de fabrication et préforme d'un contenant
HK1250496B (zh) 一種粉末化妝品組合物、用途及其製備方法
ZA201801435B (en) Insecticidal incense formulation composition, method of manufacture and applications thereof
PT3630917T (pt) Nanopartículas uniformemente encapsuladas e suas utilizações

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed